MedDataX Logo

Pulmonary Embolism After Liver Resection

NCT ID: NCT01486511

Last Updated: 2011-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Major surgery is associated with a postoperative hypercoagulable state related to the surgical trauma that may lead to thromboembolic complications. To the investigators knowledge, only two series have reported the risk of PE after liver surgery with an incidence of up to 6.3% The purpose of this study is to identify the independent risk factors associated with the development of PE after elective liver surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Disease Pulmonary Embolism Thrombophilia Death

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Liver disease Pulmonary embolism Thrombophilia Death

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liver resection patients

All patients that underwent elective liver resection for both malignant and benign diseases.

Liver resection

Intervention Type PROCEDURE

Hepatectomy including both minor and major.

Computed Tomography

Intervention Type RADIATION

Computed Tomography +/- pulmonary angiography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Liver resection

Hepatectomy including both minor and major.

Intervention Type PROCEDURE

Computed Tomography

Computed Tomography +/- pulmonary angiography

Intervention Type RADIATION

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hepatectomy, liver resection CT, CTPA, CT-PA, MSCT, MSCT-PA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years
* Malignant liver diseases
* Benign liver diseases

Exclusion Criteria

* Age \<18 years
* Previous history of thromboembolic events
* Living Donor hepatectomies
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beaujon Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emmanuel Melloul

Medical Doctor, Surgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jacques Belghiti, MD

Role: PRINCIPAL_INVESTIGATOR

Beaujon Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Prof. Jacques Belghiti

Paris, Clichy, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Beaujon

Identifier Type: -

Identifier Source: org_study_id